
Personal Chair
- About
-
- Email Address
- g.scotland@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437181
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.
- Publications
-
Page 3 of 9 Results 21 to 30 of 82
Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsThe Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis
npj Primary Care Respiratory Medicine, vol. 30, pp. 23Contributions to Journals: ArticlesGlyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: The GOT-IT RCT
Health Technology Assessment, vol. 23, no. 70, pp. 1-72Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta23700
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13665/1/Denison_GlycerylTrinitrateToReduce_VOR.pdf
- [ONLINE] View publication in Scopus
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsDarolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer
National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsEnzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer
National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsNitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK
PLoS Medicine, vol. 16, no. 12, 1003001Contributions to Journals: ArticlesLaparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial
The Lancet, vol. 394, no. 10207, pp. 1425-1436Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0140-6736(19)31790-8
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13243/1/Cooper_etal_Lancet_Laparoscopic_supracervical_VOR.pdf
- [ONLINE] https://abdn.pure.elsevier.com/en/en/researchoutput/laparoscopic-supracervical-hysterectomy-versus-endometrial-ablation-for-women-with-heavy-menstrual-bleeding-health(20b3fd84-6e08-4603-beaf-87c88732a17a).html
- [ONLINE] View publication in Scopus
Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT
Health Technology Assessment, vol. 23, no. 53, pp. 1-107Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta23530
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13068/1/HTA_REPRT_3030653_VOR.pdf
- [ONLINE] View publication in Scopus
Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins
The New England Journal of Medicine, vol. 381, no. 10, pp. 912-922Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1056/NEJMoa1805186
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13810/1/NEJMFive_year_outcomes_Brittenden_at_al_VoR.pdf
- [ONLINE] Publisher permissions
- [ONLINE] http://www.ncbi.nlm.nih.gov/pubmed/31483962
- [ONLINE] View publication in Mendeley
- [ONLINE] View publication in Scopus